Laboratory Testing and Diagnosis
ShareCompartir
- In the Absence of SARS-CoV Transmission Worldwide: Guidance for Surveillance, Clinical and Laboratory Evaluation, and Reporting Version 2 (Jan 21, 2004)
- SARS-CoV Specimen Testing Guidelines: RT-PCR and Serology (Jan 8, 2004)
Appendix F2, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS - Proficiency Testing for Public Health Laboratories Performing SARS-CoV EIA and RT-PCR Diagnostics (Jan 8, 2004)
Appendix F1, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS - Guidelines for Laboratory Diagnosis of SARS-CoV Infection (Jan 8, 2004)
Appendix F8, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS - Fact Sheet for Clinicians: Interpreting SARS-CoV Test Results from CDC and Other Public Health Laboratories (Jan 8, 2004)
Appendix F7, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS
Related Pages
- Laboratory Testing and Specimens
- Informed Consent for Laboratory Testing
- Consent Form - Coronavirus Antibody Testing
- Patient Info - Coronavirus Antibody Testing
- Consent Form - Reverse Transcription Polymerase Chain Reaction (RT-PCR) Testing
- Patient Info - Reverse Transcription Polymerase Chain Reaction or RT-PCR Testing
- Page last reviewed: May 3, 2005
- Page last updated: May 3, 2005
- Content source: